BOne marrOw transfer to enhance ST-elevation infarct regeneration -2 (BOOST-2)
- Prosjektnummer
- 911302
- Ansvarlig person
- Kenneth Dickstein
- Institusjon
- Helse Stavanger HF
- Prosjektkategori
- Forskningsprosjekt
- Helsekategori
- Cardiovascular
- Forskningsaktivitet
- 5. Treatment Developement
Long-term effects of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: 5-year results from the randomized-controlled BOOST trial--an echocardiographic study.
Eur J Echocardiogr 2009 Nov. Epub 2009 nov 28
PMID: 19946118
Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial.
Eur Heart J 2009 Dec;30(24):2978-84.
PMID: 19773226
Cell therapy for acute myocardial infarction.
Curr Opin Pharmacol 2008 Apr;8(2):202-10. Epub 2008 feb 1
PMID: 18243051
Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction.
Eur Heart J 2008 Dec;29(23):2851-8. Epub 2008 okt 25
PMID: 18953051
What are the clinical effects of bone marrow cell therapy in patients with severe coronary artery disease?
Nat Clin Pract Cardiovasc Med 2008 Jul;5(7):362-3. Epub 2008 mai 20
PMID: 18490941
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest